PDE5A and erectile dysfunction: Because inhibitors of PDE5, which is a cGMP-specific PDE, exert their pharmacological action by dilating arteries and increasing blood flow in erectile dysfunction and pulmonary hypertension6, recent studies have suggested a potential therapeutic role for PDE5 inhibitors in treating PE and FGR7,8.